These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6286796)

  • 1. The pathogenesis of pneumonitis due to murine cytomegalovirus.
    Shanley JD; Pesanti EL; Nugent KM
    J Infect Dis; 1982 Sep; 146(3):388-96. PubMed ID: 6286796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of viral replication to interstitial pneumonitis in murine cytomegalovirus lung infection.
    Shanley JD; Pesanti EL
    J Infect Dis; 1985 Mar; 151(3):454-8. PubMed ID: 2982963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial pneumonia and subclinical infection after intranasal inoculation of murine cytomegalovirus.
    Jordan MC
    Infect Immun; 1978 Jul; 21(1):275-80. PubMed ID: 213384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of immunocompetence by cyclosporin A, cyclophosphamide or protein malnutrition potentiates murine cytomegalovirus pneumonitis.
    Price P; Hopkins RM; Teo HK; Papadimitriou JM; Shellam GR
    Pathol Res Pract; 1991 Dec; 187(8):993-1000. PubMed ID: 1665228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo model for the acute, latent and reactivated phases of cytomegalovirus infection.
    Gönczöl E; Danczig E; Boldogh I; Tóth T; Váczi L
    Acta Microbiol Hung; 1985; 32(1):39-47. PubMed ID: 2994350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus-induced pneumonitis and myocarditis in newborn mice. A model for perinatal human cytomegalovirus infection.
    Fitzgerald NA; Papadimitriou JM; Shellam GR
    Arch Virol; 1990; 115(1-2):75-88. PubMed ID: 2174234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of bronchoalveolar cells during murine cytomegalovirus interstitial pneumonitis.
    Shanley JD; Ballas ZK
    Am Rev Respir Dis; 1985 Jul; 132(1):77-81. PubMed ID: 2990272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs.
    Reddehase MJ; Weiland F; Münch K; Jonjic S; Lüske A; Koszinowski UH
    J Virol; 1985 Aug; 55(2):264-73. PubMed ID: 2991554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine cytomegalovirus ocular infection in immunocompetent and cyclophosphamide-treated mice. Potentiation of ocular infection by cyclophosphamide.
    Bale JF; O'Neil ME; Folberg R
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1749-56. PubMed ID: 1851731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus.
    Tanaka K; Koga Y; Lu YY; Zhang XY; Wang Y; Kimura G; Nomoto K
    J Clin Invest; 1994 Sep; 94(3):1019-25. PubMed ID: 8083343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine models of cytomegalovirus-associated pneumonitis.
    Shanley JD
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):12-6, discussion 16. PubMed ID: 1648814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host genetic factors influence murine cytomegalovirus lung infection and interstitial pneumonitis.
    Shanley JD
    J Gen Virol; 1984 Dec; 65 ( Pt 12)():2121-8. PubMed ID: 6096490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine cytomegalovirus replication in the lungs of athymic BALB/c nude mice.
    Shanley JD; Thrall RS; Forman SJ
    J Infect Dis; 1997 Feb; 175(2):309-15. PubMed ID: 9203651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity.
    Selgrade MK; Daniels MJ; Hu PC; Miller FJ; Graham JA
    Infect Immun; 1982 Dec; 38(3):1046-55. PubMed ID: 6295940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-lymphocyte effects on murine cytomegalovirus pulmonary infection.
    Kadima-Nzuji M; Craighead JE
    Am J Pathol; 1990 Oct; 137(4):907-12. PubMed ID: 2171343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine cytomegalovirus pneumonia. Description of a model and investigation of pathogenesis.
    Rose RM; Crumpacker C; Waner JL; Brain JD
    Am Rev Respir Dis; 1982 May; 125(5):568-73. PubMed ID: 6282153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virologic and pathogenetic aspects of cytomegalovirus infection.
    Grundy JE
    Rev Infect Dis; 1990; 12 Suppl 7():S711-9. PubMed ID: 2173100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection.
    Jordan MC; Takagi JL; Stevens JG
    J Infect Dis; 1982 May; 145(5):699-705. PubMed ID: 6281340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of T cells in mouse cytomegalovirus myocarditis.
    Lawson CM; O'Donoghue H; Reed WD
    Immunology; 1989 May; 67(1):132-4. PubMed ID: 2544512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging and reactivation of latent murine cytomegalovirus.
    Schmader KE; Rahija R; Porter KR; Daley G; Hamilton JD
    J Infect Dis; 1992 Dec; 166(6):1403-7. PubMed ID: 1331252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.